Eagle Health Investments’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27.3M Sell
217,200
-7,900
-4% -$993K 6.74% 6
2025
Q1
$24.9M Buy
225,100
+70,100
+45% +$7.75M 6.46% 7
2024
Q4
$21.2M Buy
155,000
+26,400
+21% +$3.6M 5.19% 10
2024
Q3
$14.8M Buy
+128,600
New +$14.8M 2.81% 15